| Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
|---|
| 05/31/2006 | CN1257892C New indole derivatives with 5-HT6 receptor affinity |
| 05/31/2006 | CN1257886C Dehydroamino acids compounds |
| 05/30/2006 | US7053234 Antibacterial agents |
| 05/30/2006 | US7053211 Process for the preparation of α-aminosubstituted carboxylic acid amides |
| 05/30/2006 | US7053122 Brain disorders; central nervous system disorders; anxiolytic agents; analgesics; sleep disorders |
| 05/30/2006 | US7053109 Aminediols for the treatment of Alzheimer's disease |
| 05/30/2006 | US7053104 Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases |
| 05/30/2006 | US7053088 Vanilloid receptor ligands and their use in treatments |
| 05/30/2006 | US7053078 Serine protease inhibitors |
| 05/30/2006 | US7053071 Induction of apoptosis in cancer cells |
| 05/26/2006 | WO2006055725A2 Substituted amino acids as protein tyrosine phosphatase inhibitors |
| 05/26/2006 | WO2006055463A2 2-amino-3-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors |
| 05/26/2006 | WO2006055462A1 2-amino-4-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors |
| 05/26/2006 | WO2006055435A1 2-aminonaphthalene derivatives and related glycogen phosphorylase inhibitors |
| 05/26/2006 | WO2006055187A1 Sulfonyl-substituted bicyclic compounds as modulators of ppar |
| 05/26/2006 | WO2006054491A1 Process for producing n-(3-chloro-1h-indol-7-yl)-4-sulfamoylbenzenesulfonamide |
| 05/26/2006 | WO2006054456A1 Crystal of two-ring heterocyclic sulfonamide compound |
| 05/26/2006 | WO2006054162A1 Azabicyclic muscarinic receptor antagonists |
| 05/26/2006 | WO2006053700A1 Agonists and antagonists of the somatostatin receptor |
| 05/26/2006 | WO2006053440A1 New processes for the preparation of optically pure indoline-2-carboxylic acid and n-acetyl-indoline-2-carboxylic acid |
| 05/26/2006 | WO2006012162A3 Methods for producing and purifying 2-hydrocarbyl-3,3-bis(4-hydroxyaryl)phthalimidine monomers and polycarbonates derived therefrom |
| 05/26/2006 | WO2006002361A3 2-methylpropanamides and their use as pharmaceuticals |
| 05/26/2006 | WO2005108358A3 Pyrrolidine derivatives useful as bace inhibitors |
| 05/26/2006 | CA2588776A1 Substituted amino carboxylic acids |
| 05/26/2006 | CA2585172A1 Sulfonyl-substituted bicyclic compounds as modulators of ppar |
| 05/26/2006 | CA2582384A1 Agonists and antagonists of the somatostatin receptor |
| 05/25/2006 | US20060111427 Indole derivatives useful as progesterone receptor modulators |
| 05/25/2006 | US20060111426 Indole-3-sulphur derivaties |
| 05/25/2006 | US20060111425 To treat diseases of respiratory, urinary and gastrointestinal systems; highly selective; significant potency; (2R,2S)(1 alpha ,5 alpha ,6 alpha )-N-{-[4-(1,3-dioxo-1,3-dihydro-isoindol-2-yl)-butyl]-3-azabicyclo[3.1.0]hex-6-yl-methyl}-2-hydroxy-2-cyclopentyl-2-phenylacetamide |
| 05/25/2006 | US20060111424 Treating nuclear hormone receptor-associated conditions such as cancer and immune disorders; (3a alpha ,4 alpha ,7 alpha ,7a alpha )-2-(3-Chloro-4-hydroxyphenyl)hexahydro-4,7-methano-1H-isoindole-1,3(2H)-dione |
| 05/25/2006 | US20060111339 Novel oral general anesthetics and metabolitically resistant anticonvulsants |
| 05/25/2006 | US20060111304 For therapy of pancreatitus, bilioecholic, gastroesophical relux (GERD), irritable bowel syndrome (IBS), non ulcerous dyspepsia |
| 05/25/2006 | US20060111303 N-[(1S)-3-{(2Z)-2-[(4R)-3,4-dimethyl-1,3-thiazolidin-2-ylidene]hydrazino}-2,3-dioxo-1-(tetrahydro-2H-pyran-4-yl)propyl]cycloheptanecarboxamide; cysteine protease inhibitors; for the treatment of inflammatory, immune, ischemic, respiratory,circulatory, neuronal, blood, hepatic and metabolic diseases |
| 05/24/2006 | EP1658267A2 Inhibitors of cathepsin s |
| 05/24/2006 | EP1658068A1 Novel cycloalkyl'b! condensed indoles |
| 05/24/2006 | EP1658067A1 Indolamide derivatives which possess glycogen phosphorylase inhibitory activity |
| 05/24/2006 | EP1658066A2 Adamantylglycine- based inhibitors of dipeptidyl peptidase iv for the treatment of diabetes |
| 05/24/2006 | EP1370526B1 Diamides which inhibit tryptase and factor xa activity |
| 05/24/2006 | EP1334106B1 Imidazole derivatives, production method thereof and use thereof |
| 05/24/2006 | EP1212298B1 Isolation of natural l-beta-3-indolylalanine and enrichment of natural aliphatic amino acid mixtures with natural l-beta-3-indolylalanine |
| 05/24/2006 | EP1100492B1 INDOLE sPLA2 INHIBITORS |
| 05/24/2006 | DE10347386B4 Tetrahydronaphthalinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer Tetrahydronaphthalene derivatives, processes for their preparation and their use as anti-inflammatories |
| 05/24/2006 | CN1777583A Methods for producing cyclic benzamidine derivatives |
| 05/24/2006 | CN1777582A Substituted indoline and indole derivatives |
| 05/24/2006 | CN1775763A Carboxyl acylamide compound and its preparing method and use |
| 05/24/2006 | CN1775759A Bicyclic androgen and progesterone receptor modulator compounds and methods |
| 05/24/2006 | CN1775754A Indole preparing method |
| 05/24/2006 | CN1256998C Sublimation purifying method and apparatus |
| 05/23/2006 | US7049468 Method for modulating the activity of a Rho C enzyme, comprising: contacting said Rho C enzyme with an effective amount of a compound of formula 1: |
| 05/23/2006 | US7049448 Reacting cyclohexanedione with diol in halogenated solvent in presence of acid catalyst |
| 05/23/2006 | US7049445 for treating or preventing diabetes, obesity, hyperlipidemia, digestive diseases, depression or urinary disturbances; beta 3-agonist |
| 05/23/2006 | US7049444 3-azabicyclo[3.1.0]hexane derivatives useful in therapy |
| 05/23/2006 | US7049335 3-azabicyclo[3.1.0]hexane derivatives |
| 05/23/2006 | US7049330 Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents |
| 05/23/2006 | US7049326 Altering a drug's distribution, metabolism and elimination properties, especially by modifying with aralkyl ester moieties to increase rate of metabolism to inactive and nontoxic metabolites when exposure is halted; surgery, riots |
| 05/23/2006 | US7049316 Prodrugs of CC-1065 analogs |
| 05/23/2006 | US7049314 Cyclopentyl indole derivatives |
| 05/23/2006 | CA2339630C Carboline derivatives as cgmp phosphodiesterase inhibitors |
| 05/23/2006 | CA2173747C Calcium receptor-active arylalkyl amines |
| 05/22/2006 | CA2488324A1 Optical resolution of n-acetyl-indoline-2-carboxylic acid with phenylglycinol |
| 05/18/2006 | WO2006051399A1 Piperazine derivatives useful as adrenergic receptor antagonists |
| 05/18/2006 | WO2006051374A2 Arylpiperazines useful as adrenergic receptor antagonists |
| 05/18/2006 | WO2006051047A1 N-substituted imides as polymerization initiators |
| 05/18/2006 | WO2006034480A3 Sulfonamide bicyclic compounds |
| 05/18/2006 | WO2006012504A3 Compounds and methods for treatment of thrombosis |
| 05/18/2006 | WO2005051301A3 Heterocyclic inhibitors of mek and methods of use thereof |
| 05/18/2006 | US20060106256 e.g. 1-[(benzylamino)methyl]-3-(3,5-difluorophenyl)-2-({3-[(dipropylamino)carbonyl]benzoyl}amino)propyl 4-nitrophenyl carbonate; secretase inhibitors; neurodegenerative disorders; Alzheimer's, Parkinson's diseases, Down syndrom, Hereditary Cerebral Hemorrhage with Amyloidosis of the Dutch-Type |
| 05/18/2006 | US20060106227 3-'2-(Dimethylamino) ethyl!-n-methyl-1h-indole-5-methanesulfonamide and the succinate thereof |
| 05/18/2006 | US20060106226 Isolation of amino acids and related isolates |
| 05/18/2006 | US20060106086 Preparation of tegaserod and tegaserod maleate |
| 05/18/2006 | US20060106067 Androgen receptor agonist; prostate cancer, hypogonadism; 4-[4-(hydroxymethyl)-1-piperidinyl]-1-naphthonitrile; 4-(4-hydroxy-2-methyl-1-pyrrolidinyl-1-benzothiophene-7-carbonitrile |
| 05/18/2006 | US20060106053 Therapy of adenocarcinoma of the colon and rectum |
| 05/18/2006 | US20060105441 Process for the preparation of indole derivatives by enzymatic acylation |
| 05/18/2006 | US20060105257 Indolenine compound, near infrared absorber, and toner containing the same |
| 05/17/2006 | EP1656348A1 Acetylene derivatives as inhibitors of histone deacetylase |
| 05/17/2006 | EP1656347A1 Substituted indole derivatives for pharmaceutical composition for treating respiratory diseases |
| 05/17/2006 | EP1656346A1 Novel substituted 3-sulfur indoles |
| 05/17/2006 | EP1656141A1 Treatment for alzheimer s disease and related conditions |
| 05/17/2006 | EP1656134A1 Indoline-sulfanilic acid amides used as ppar delta modulators |
| 05/17/2006 | CN1256325C Process for cascade reaction preparation of N-acetyl-DL-tryptophan |
| 05/16/2006 | US7045544 Myocardium; angina pectoris |
| 05/16/2006 | US7045532 ACE-2 modulating compounds and methods of use thereof |
| 05/16/2006 | US7045521 Cyclic amide derivative as monocyte chemotactic protein modulator; prevention and treatment of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma; antiinflammatory agents |
| 05/16/2006 | US7045360 Method for analysis of reaction products |
| 05/16/2006 | CA2237752C Novel substituted aryl compounds useful as modulators of acetylcholine receptors |
| 05/16/2006 | CA2192797C Indolinone compounds for the treatment of disease |
| 05/11/2006 | WO2006050120A2 Synthesis of cox-2 and faah inhibitors |
| 05/11/2006 | WO2006049889A1 Indole derivatives useful as progesterone receptor modulators |
| 05/11/2006 | WO2006049835A2 Indole and benzimidazole derivatives |
| 05/11/2006 | WO2006048893A2 A process for synthesis of large particle size statin compounds |
| 05/11/2006 | WO2006048727A1 Piperazinylphenalkyl lactam/amine ligands for the 5ht1b receptor |
| 05/11/2006 | WO2006048236A1 Process for the preparation of alkyl 5- (dicarboximido) levulinate and alkyl 4-oxo-pentenoate |
| 05/11/2006 | WO2006047888A1 2-substituted indoles, their precursors and novel processes for the preparation thereof |
| 05/11/2006 | US20060100283 Phenylcyclohexylpropanolamine derivatives, preparation and therapeutic application thereof |
| 05/11/2006 | US20060100266 3-(2-Dimethylaminoethyl)-7-fluoro-1-methyl-1H-indol-4-ol; Obsessive Compulsive Disorder; appetite suppressants |
| 05/11/2006 | US20060100265 4-(1-(sulfonyl)-1h-indol-2-yl)-4-(hydroxy)-cyclohexa-2,5-dienone compounds and analogs thereof as therapeutic agents |
| 05/11/2006 | US20060100230 Indolin phenylsulfonamide derivatives |
| 05/11/2006 | US20060100202 Novel compounds |
| 05/11/2006 | US20060100196 Substituted amines for the treatment of alzheimer's disease |
| 05/11/2006 | US20060099638 incorporating indolium ring moiety substituted at 3-position improves spectral properties; for detection of ligands; hybridization probes |